Cardiac Imaging News

FDG PET/CT, A New Technique For Imaging Aortic Dissection…

In a recent study, carried out in Germany, researchers designed a new procedure for imaging a rare cardiac condition, the aortic dissection, which is a highly fatal disease that causes mortalities without warning. During the study, researchers were able to capture images of this rare cardiac ailment. The study was published in the Journal of Nuclear Medicine. The study was led by Hans-Henning Eckstein, M.D., Ph.D, of the Technical University of Munich, he and his team ... Read more

Cardiac Imaging, Benefits And Risks…

During the examination of patients having chest pain or other cardiac risk factors, doctors are depending increasingly on nuclear imaging and computed tomography (CT) scans to check the conditions of these patients. Such techniques have proved to be ... Read more

Lantheus Selects A New Vice President For Clinical …

Lantheus Medical Imaging, Inc. a company producing cardiac imaging solutions, announced that it has selected Dana S. Washburn, MD, FACC, to serve the company as the newly created position of vice president, clinical development and medical affairs. Washburn will join Lantheus coming from Boston Scientific Corporation, Boston, where she was serving as vice president, clinical trials and safety, and medical safety officer. At Lantheus, Washburn is going to be in charge of the clinical trials team, managing the development of the company’s latest diagnostic imaging agents, in addition to providing continuos medical and safety assistance for the existing product line of Lantheus, which includes DEFINITY and Cardiolite. President and CEO of Lantheus, Don Kiepert, mentioned that selecting Washburn to be a vice president shows that the company is always committed to confirm the highest possible safety standards for its products.On the other hand, Washburn said “Lantheus provides me with a unique opportunity to broaden the application of my experience in clinical development and cardiovascular imaging across a spectrum of products and modalities. I look forward to leading the company's clinical development efforts and in working to further develop its ... Read more

A New Device Monitors And Measures Risk For …

Two device mechanical engineering professors, Stanley Kleis and Ralph Metcalfe, at University of Houston helped develop a new device called VENDYS which allows doctors to monitor the changes of temperature in the fingerprint, which is affected by ... Read more

A New Article Highlights Molecular Imaging Of …

The Journal of Nuclear Medicine (JNM) has published Multimodality Molecular Imaging of the Cardiovascular System; the article is highlighting the technology of cardiovascular molecular imaging and reviewing the obstacles standing against the ... Read more

Stents Show Effectiveness In Repairing Aortas…

The effectiveness of using stents to repair aortas that are torn as the result of accidents has been shown by a UC Davis team of cardiovascular specialists and that's in comparison with the traditional open-chest surgery. The stents used in the UC ... Read more

Agfa HealthCare Launches Imapx Cardiovascular Suite …

Agfa HealthCare launched remote capabilities which expand the accessibility of its Impax Cardiovascular Suite throughout the hospital enterprise. Now, the Imapx CRS Remote enables Microsoft Windows devices within the hospital enterprise to become virtual cardiovascular review stations that allow clinicians to access modality-specific toolkits, and interact with programs via a single point of access. Basically, ImapxCRS Remote is developed to provide high-fidelity imaging for cine loops used in cardiovascular imaging. For example, via Citrix XenDesktop technology, the Remote streams video at more than 30 frames per second for angiography images. Michael Green, vice president North America, Agfa HealthCare, said “By offering a full desktop review station experience from any Microsoft Windows device in the hospital enterprise, Impax CRS Remote frees clinicians from the confines of the cardiology reading room, to improve the timeliness and delivery of healthcare.” Moreover, Imapx CRS Remote helps facilitate its users’ compliance with security regulations by allowing for role-based access. Further, the Impax CRS Remote supports multimodality image review and reporting for cardiac catheterization, echocardiography, vascular ultrasound, and nuclear ... Read more

Mount Sinai Is Using A New Diagnostic Imaging Device…

It is a fact that diagnostic imaging is one of the fast growing fields. There is continuos development and new techniques and devices are produced every now and then. Diagnostic imaging has always aimed to provide help for radiologists and hope for their patients to have improved capabilities of diagnosis and treatment. In order to make use of the new advances, Mount Sinai Medical Center announced that it has started, recently,  to use a new cadmium zinc telluride (CZT) camera to carry out cardiac nuclear imaging studies. Milena J. Henzlova, M.D., professor of medicine (cardiology) at Mount Sinai School of Medicine, said in an interview with Tech Edge, that the camera has significantly improved the abilities of the department. It has also reduced exposure time by nearly five-fold, which means that radiation exposure was decreased from 40% to 60%. Henzlova added that since the most of cardiac patients are either older or ill, these patients had, sometimes, to retake exams and undergo procedures that involve radiation exposures up to 20 minutes. She added that reducing dose rate is an important enhancement as coronary disease are still able to be treated at a younger age which makes decreasing radiation exposure important on the long term. Moreover, Henzlova added that the use of the new CZT camera had other advantages; in addition to improve the safety of patients, which is the enhanced quality of the produced images, she said “I think the images are better.” Mount Sinai Medical Center is using the new CZT system from GE Healthcare. The system includes focused pin-hole collimation allowing better detecting efficiency, generating improved image quality and speed; stationary data acquisition, which manages all views in the same time during a fully stationary SPECT acquisition, virtually preventing motion artifacts and reducing scan times; and 3D ... Read more

Iranian President Inaugurates A New Cardiac …

President of Iran, Mahmoud Ahmadinejad, has opened a cardiac bio-implant factory in Kish Island south of Iran on Friday. The price of Iran-made cardiac valve is much lesser than its world price by 2800 dollars. The surface of implants that contact ... Read more

BioMedica Diagnostics Releases QuikCoag Solution…

BioMedica Diagnostics released QuikCoag, which is developed for monitoring the growing prevalence of heart disease. "The revenue base from our existing markets is being applied to leverage the introduction of affordable medical solutions in ... Read more

Predictions Of Cardiac Diseases Improved Using A New …

According to a new study, using a computed tomography (CT) test to measure calcium in coronary arteries enhances the predictions of future cardiac disease. Yet, it is not confirmed if the new test deserves the costs and risk due to radiation ... Read more

Gene Expression Test Substitutes Invasive Heart Muscle …

A new study, called Invasive Monitoring Attenuation by Gene Expression (IMAGE), has found that using a simple blood test to monitor the rejection in heart transplantation patients can safely lowers the need for invasive heart-muscle biopsies. The test is called AlloMap molecular expression testing. It measures 11 genes from molecular pathways in white blood cells associated with heart transplant rejection. It's the first transplantation test cleared by the U.S. Food and Drug Administration. The test was developed by Dr. Mario Deng, director of cardiac transplantation research at Columbia University Medical Center, associate professor of medicine at Columbia University College of Physicians and Surgeons and a cardiologist at New York-Presbyterian Hospital/Columbia University Medical Center. Results were presented at the Annual Scientific Meeting of the International Society for Heart and Lung Transplantation in Chicago and published in the New England Journal of Medicine. "The genomics revolution initiated by the completion of the Human Genome Project has made possible what was only dreamed about before -- namely the ability to improve patient care by ruling out rejection without taking an invasive heart tissue sample," says Dr. Mario Deng The study involved 602 patients, who were 6 months to 5 years since their heart transplantation, were randomly assigned to undergo rejection monitoring using either gene-expression profiling or routine endomyocardial biopsy. They compared the two groups and found that both groups had similar two-year cumulative rates of the composite primary outcome. The two-year rates of all-cause mortality were also similar in the gene-expression profiling and biopsy arms. Patients in the gene-expression profiling group underwent one-sixth the number of biopsies per person-year of follow-up compared with patients in the biopsy group. They also found that it was a safe approach and was preferred by patients which resulted in significantly reducing biopsies. Dr. Deng says "As the country's largest heart transplant program, our Hospital is taking the lead in offering our patients this cutting-edge tool to improve patients' quality of ... Read more

Atrial Fibrillation Is Linked To People With Diabetes …

Atrial fibrillation is the most common kind of chronically irregular heartbeat and it has been associated with diabetes according to some research. Although there have been conflicts over this connection, Dr. Sascha Dublin of Group Health Research ... Read more

Page 12 of 15

These signals are relayed buying clomid online safe which then is by a number of such as medial preoptic and paraventricular nulcei.
javporn.cc